These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 18205187
1. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA. Cancer; 2008 Mar 01; 112(5):1020-7. PubMed ID: 18205187 [Abstract] [Full Text] [Related]
2. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment. Altorki NK, Lee PC, Liss Y, Meherally D, Korst RJ, Christos P, Mazumdar M, Port JL. Ann Surg; 2008 Mar 01; 247(3):434-9. PubMed ID: 18376186 [Abstract] [Full Text] [Related]
3. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk. Newton AD, Predina JD, Xia L, Roses RE, Karakousis GC, Dempsey DT, Williams NN, Kucharczuk JC, Singhal S. Ann Surg Oncol; 2018 Jan 01; 25(1):318-325. PubMed ID: 29147928 [Abstract] [Full Text] [Related]
4. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TT. Am J Surg Pathol; 2005 Aug 01; 29(8):1079-85. PubMed ID: 16006804 [Abstract] [Full Text] [Related]
5. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients. Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Ann Surg Oncol; 2008 Jan 01; 15(1):104-16. PubMed ID: 17891442 [Abstract] [Full Text] [Related]
6. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. Lee L, Ronellenfitsch U, Hofstetter WL, Darling G, Gaiser T, Lippert C, Gilbert S, Seely AJ, Mulder DS, Ferri LE. J Am Coll Surg; 2013 Aug 01; 217(2):191-9. PubMed ID: 23659947 [Abstract] [Full Text] [Related]
7. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Leers JM, DeMeester SR, Oezcelik A, Klipfel N, Ayazi S, Abate E, Zehetner J, Lipham JC, Chan L, Hagen JA, DeMeester TR. Ann Surg; 2011 Feb 01; 253(2):271-8. PubMed ID: 21119508 [Abstract] [Full Text] [Related]
8. Esophageal submucosa: the watershed for esophageal cancer. Raja S, Rice TW, Goldblum JR, Rybicki LA, Murthy SC, Mason DP, Blackstone EH. J Thorac Cardiovasc Surg; 2011 Dec 01; 142(6):1403-11.e1. PubMed ID: 22093714 [Abstract] [Full Text] [Related]
9. Lymph node metastasis in early esophageal adenocarcinoma. Griffin SM, Burt AD, Jennings NA. Ann Surg; 2011 Nov 01; 254(5):731-6; discussion 736-7. PubMed ID: 21997815 [Abstract] [Full Text] [Related]
10. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction. Zhang X, Watson DI, Jamieson GG. Chin Med J (Engl); 2007 Dec 20; 120(24):2268-70. PubMed ID: 18167216 [Abstract] [Full Text] [Related]
11. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Maish MS, DeMeester SR. Ann Thorac Surg; 2004 Nov 20; 78(5):1777-82. PubMed ID: 15511474 [Abstract] [Full Text] [Related]
12. Lymphatic vessel invasion is a significant prognostic indicator in stage IA lung adenocarcinoma. Funai K, Sugimura H, Morita T, Shundo Y, Shimizu K, Shiiya N. Ann Surg Oncol; 2011 Oct 20; 18(10):2968-72. PubMed ID: 21512862 [Abstract] [Full Text] [Related]
13. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DM. Am J Surg Pathol; 2011 Jul 20; 35(7):1045-53. PubMed ID: 21602659 [Abstract] [Full Text] [Related]
14. Refining esophageal cancer staging. Rice TW, Blackstone EH, Rybicki LA, Adelstein DJ, Murthy SC, DeCamp MM, Goldblum JR. J Thorac Cardiovasc Surg; 2003 May 20; 125(5):1103-13. PubMed ID: 12771884 [Abstract] [Full Text] [Related]
15. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. Cancer; 2006 Mar 01; 106(5):1017-25. PubMed ID: 16456809 [Abstract] [Full Text] [Related]
16. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status. Leers JM, Ayazi S, Hagen JA, Terterov S, Klipfel N, Oezcelik A, Abate E, Lipham JC, DeMeester SR, Banki F, DeMeester TR. J Am Coll Surg; 2009 Apr 01; 208(4):553-6. PubMed ID: 19476789 [Abstract] [Full Text] [Related]
17. Prediction of lymph node status in superficial esophageal carcinoma. Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, Portale G, Cavallin F, Rugge M. Ann Surg Oncol; 2008 Nov 01; 15(11):3278-88. PubMed ID: 18726651 [Abstract] [Full Text] [Related]
18. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? Bollschweiler E, Baldus SE, Schröder W, Schneider PM, Hölscher AH. J Surg Oncol; 2006 Oct 01; 94(5):355-63. PubMed ID: 16967455 [Abstract] [Full Text] [Related]
19. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Ann Surg Oncol; 2007 Feb 01; 14(2):306-16. PubMed ID: 17091329 [Abstract] [Full Text] [Related]
20. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, Andrews S, Hamilton SM. Ann Surg Oncol; 2004 Jun 01; 11(6):629-35. PubMed ID: 15150070 [Abstract] [Full Text] [Related] Page: [Next] [New Search]